InvestSMART

Vectus Biosystems Limited (ASX: VBS) - Announcements

- Current share price for VBS : $0.185

ASX company news and announcements for Vectus Biosystems Limited (VBS) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Vectus Biosystems Limited (VBS) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Vectus Biosystems Limited (VBS), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Vectus Biosystems Limited (VBS)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$11 Full Year Statutory Accounts 31 Aug 2026 7:50AM $0.185 $0.185 fallen by 0%
$11 Preliminary Final Report 31 Aug 2026 7:50AM $0.185 $0.185 fallen by 0%
$11 Cleansing Notice 29 Jul 2026 6:25PM $0.130 $0.185 risen by 42.31%
$11 Application for quotation of securities - VBS 29 Jul 2026 6:21PM $0.130 $0.185 risen by 42.31%
$11 Quarterly Activities & Appendix 4C Cash Flow Reports 28 Jul 2026 5:58PM $0.150 $0.185 risen by 23.33%
$11 VBS Engages CHRS as Regulatory Agent for FDA Submissions 13 Jul 2026 9:53AM $0.160 $0.185 risen by 15.63%
$11 Cleansing Notice 26 Jun 2026 4:19PM $0.125 $0.185 risen by 48%
$11 Application for quotation of securities - VBS 26 Jun 2026 4:14PM $0.125 $0.185 risen by 48%
$11 CEO Investor Webinar 17 Jun 2026 8:17AM $0.145 $0.185 risen by 27.59%
$11 Change in substantial holding 29 May 2026 5:17PM $0.110 $0.185 risen by 68.18%
$11 Change in substantial holding KHPL 28 May 2026 9:57AM $0.105 $0.185 risen by 76.19%
$11 Cleansing Notice 27 May 2026 7:15PM $0.105 $0.185 risen by 76.19%
$11 Application for quotation of securities - VBS 27 May 2026 11:56AM $0.105 $0.185 risen by 76.19%
$11 Proposed issue of securities - VBS 22 May 2026 5:03PM $0.115 $0.185 risen by 60.87%
$11 Placement of Shares 22 May 2026 3:18PM $0.105 $0.185 risen by 76.19%
$11 Updated Corporate Presentation 15 May 2026 8:20AM $0.115 $0.185 risen by 60.87%
$11 Cleansing Notice 12 May 2026 5:26PM $0.125 $0.185 risen by 48%
$11 Application for quotation of securities - VBS 12 May 2026 5:21PM $0.125 $0.185 risen by 48%
$11 Cleansing Notice 8 May 2026 3:33PM $0.125 $0.185 risen by 48%
$11 Application for quotation of securities - VBS 8 May 2026 3:29PM $0.125 $0.185 risen by 48%
$11 Notification regarding unquoted securities - VBS 8 May 2026 3:25PM $0.125 $0.185 risen by 48%
$11 Appointment of Dr Tara Speranza as CEO & CTO 7 May 2026 5:09PM $0.125 $0.185 risen by 48%
$11 Quarterly Activities & Appendix 4C Cash Flow Reports 30 Apr 2026 3:10PM $0.120 $0.185 risen by 54.17%
$11 VB4-P5 Renal Compound Transaction Settled 14 Apr 2026 8:12AM $0.150 $0.185 risen by 23.33%
$11 Half Year Report & Appendix 4D 26 Feb 2026 12:25PM $0.140 $0.185 risen by 32.14%

1 - 25 of 327 results

Page 1 of 14

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.